Effect of transient and permanent permeability transition pore opening on NAD(P)H localization in intact cells.
To study the effect of mitochondrial permeability transition pore (PTP) opening on NAD(P)H localization, intact cells were exposed to the Ca(2+) ionophore A23187. PTP opening, mitochondrial membrane potential, mitochondrial volume, and NAD(P)H localization were assessed by time-lapse laser confocal microscopy using the calcein-cobalt technique, tetramethylrhodamine methyl ester, MitoTracker, and NAD(P)H autofluorescence, respectively. Concomitant with PTP opening, NAD(P)H fluorescence increased outside mitochondria. These events occurred in all cells and were prevented by cyclosporin A. Mitochondrial membrane potential was not systematically collapsed, whereas mitochondrial volume did not change, confirming that A23187 induced transient PTP opening in a subpopulation of cells and suggesting that mitochondrial swelling did not immediately occur after PTP opening in intact cells. NAD(P)H autofluorescence remained elevated after PTP opening, particularly after membrane potential had been collapsed by an uncoupler. Extraction of nucleotide for NAD(P)H quantification confirmed that PTP opening led to an increase in NAD(P)H content. Because the oxygen consumption rate decreased, whereas the lactate/pyruvate ratio increased after PTP opening in intact cells, we conclude that PTP opening inhibits respiration and dramatically affects the cytosolic redox potential in intact cells.
Dumas
Jean François
JF
INSERM, U884, F-38041 Grenoble, France.
Argaud
Laurent
L
Cottet-Rousselle
Cécile
C
Vial
Guillaume
G
Gonzalez
Cécile
C
Detaille
Dominique
D
Leverve
Xavier
X
Fontaine
Eric
E
D001692:Biological Transport / Q000187:drug effects; D002460:Cell Line; D019069:Cell Respiration / Q000187:drug effects; D002469:Cell Separation; D005453:Fluorescence; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D021621:Imaging, Three-Dimensional; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D033681:Mitochondrial Membrane Transport Proteins / Q000378:metabolism*; D000083162:Mitochondrial Permeability Transition Pore; D009243:NAD / Q000494:pharmacology; D009249:NADP / Q000378:metabolism*; D053141:Organelle Size / Q000187:drug effects; D010084:Oxidation-Reduction / Q000187:drug effects
D033681:Mitochondrial Membrane Transport Proteins; D000083162:Mitochondrial Permeability Transition Pore; D009243:NAD; D009249:NADP